Werba Rubin Papier Wealth Management Gilead Sciences, Inc. Transaction History
Werba Rubin Papier Wealth Management
- $460 Billion
- Q1 2025
A detailed history of Werba Rubin Papier Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Werba Rubin Papier Wealth Management holds 7,876 shares of GILD stock, worth $817,686. This represents 0.19% of its overall portfolio holdings.
Number of Shares
7,876
Previous 7,916
0.51%
Holding current value
$817,686
Previous $731 Million
20.7%
% of portfolio
0.19%
Previous 0.17%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,247Shares Held
998MCall Options Held
8.86MPut Options Held
8.69M-
Black Rock Inc. New York, NY121MShares$12.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.2 Billion0.25% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.27 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.67 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.56 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...